Results 41 to 50 of about 2,247,449 (357)
Ribosomopathies: New Therapeutic Perspectives
Ribosomopathies are a group of rare diseases in which genetic mutations cause defects in either ribosome biogenesis or function, given specific phenotypes.
Emilien Orgebin +6 more
doaj +1 more source
Dental caries is a chronic, progressive disease caused by plaque, influenced by multiple factors and can damage the hard tissues of the teeth. In severe cases, it can also lead to the onset and development of other oral diseases, seriously affecting ...
Shanlin Qu +7 more
doaj +1 more source
sLZIP functions as a key modulator of bone remodeling by regulating the crosstalk between osteoblasts and osteoclasts. [PDF]
Park S, Kim J, Ko J.
europepmc +3 more sources
The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem
Osteosarcomas are the most frequent primary bone sarcomas, affecting mainly children, adolescents, and young adults, and with a second peak of incidence in elderly individuals.
Isabelle Corre +4 more
doaj +1 more source
Immunohistochemical Evaluation of Bone Remodeling Following Compressive Force on Mandibular Condyle. [PDF]
Lyros I +9 more
europepmc +3 more sources
RANKL/RANK/OPG Pathway: A Mechanism Involved in Exercise-Induced Bone Remodeling
Bones as an alive organ consist of about 70% mineral and 30% organic component. About 200 million people are suffering from osteopenia and osteoporosis around the world.
Mohammad Tobeiha +3 more
semanticscholar +1 more source
BackgroundDexamethasone (DEX) exerts anti-inflammatory and osteogenic effects. Hydroxyapatite is commonly used in bone repair due to its osteoconductivity, osseointegration, and osteogenesis induction. Hollow hydroxyapatite (HHAM) is often used as a drug
Xiaoli Liu +6 more
doaj +1 more source
The 3D arrangement of porous granular biomaterials usable to fill bone defects has received little study. Granular biomaterials occupy 3D space when packed together in a manner that creates a porosity suitable for the invasion of vascular and bone cells.
Daniel eCHAPPARD +6 more
doaj +1 more source
Tiludronate and clodronate do not affect bone structure or remodeling kinetics over a 60 day randomized trial [PDF]
Background Tiludronate and clodronate are FDA-approved bisphosphonate drug therapies for navicular disease in horses. Although clinical studies have determined their ability to reduce lameness associated with skeletal disorders in horses, data regarding
Gillett, Ashley N. +3 more
core +1 more source
Towards a New Spatial Representation of Bone Remodeling [PDF]
Irregular bone remodeling is associated with a number of bone diseases such as osteoporosis and multiple myeloma. Computational and mathematical modeling can aid in therapy and treatment as well as understanding fundamental biology.
Ayati, Bruce P. +3 more
core +2 more sources

